AZATHIOPRINE , ADALIMUMAB , METHOTREXATE , GOLIMUMAB , Vixarelimab, -, -, INFLIXIMAB , -, MERCAPTOPURINE , -, Vixarelimab Placebo clinical trials

A Phase II, Multicenter Induction Study with an Active Treatment Extension to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Patients with Moderate to Severe Ulcerative Colitis

This study is testing a new drug, called Vixarelimab, for adults with moderate to severe ulcerative colitis. It aims to see how well it works to reduce symptoms and improve the gut, as well as checking its safety and how the body handles it.